Coherus BioSciences Inc
NASDAQ:CHRS
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Coherus BioSciences Inc
NASDAQ:CHRS
|
US |
|
Main Street Capital Corp
NYSE:MAIN
|
US |
|
M/I Homes Inc
NYSE:MHO
|
US |
|
Citius Pharmaceuticals Inc
NASDAQ:CTXR
|
US |
|
A
|
Active Biotech AB publ
STO:ACTI
|
SE |
|
Siriuspoint Ltd
NYSE:SPNT
|
BM |
|
HIVE Blockchain Technologies Ltd
XTSX:HIVE
|
CA |
|
Howmet Aerospace Inc
NYSE:HWM
|
US |
|
AES Corp
NYSE:AES
|
US |
|
G
|
Garmin Ltd
NYSE:GRMN
|
CH |
|
Philip Morris International Inc
NYSE:PM
|
US |
|
Hong Kong and China Gas Co Ltd
HKEX:3
|
HK |
|
Elevance Health Inc
NYSE:ELV
|
US |
|
Amalgamated Bank
NASDAQ:AMAL
|
US |
|
Taiwan Semiconductor Manufacturing Co Ltd
TWSE:2330
|
TW |
|
Playstudios Inc
NASDAQ:MYPS
|
US |
|
Shore Bancshares Inc
NASDAQ:SHBI
|
US |
|
Blink Charging Co
NASDAQ:BLNK
|
US |
|
H
|
Hana Microelectronics PCL
SET:HANA
|
TH |
|
Littelfuse Inc
NASDAQ:LFUS
|
US |
|
Paccar Inc
NASDAQ:PCAR
|
US |
Bankruptcy Probability
Coherus BioSciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Coherus BioSciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Coherus BioSciences Inc
NASDAQ:CHRS
|
235.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
379.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
182.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
162.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
67.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
43.7B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
|
40.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Coherus BioSciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Coherus BioSciences Inc has total debt of 51.1m USD. This includes both short-term (0 USD) and long-term (51.1m USD) debt.
You can find a full breakdown on its Balance Sheet.
